Sort   by:  
 Page size 
UnknownPhase II study of MEK inhibitor trametinib alone and in combination with AKT inhibitor GSK2141795/uprosertib in patients with metastatic triple negative breast cancer.
Not available
S-EPMC12796985 | biostudies-literature
UnknownIn-person cognitive behavioural therapy vs. usual care after surgical management of extremity fractures: an unsuccessful feasibility trial.
Not available
S-EPMC10770933 | biostudies-literature
UnknownCognitive Behavioural Therapy to Optimize Post-Operative Fracture Recovery (COPE): protocol for a randomized controlled trial.
Not available
S-EPMC9587572 | biostudies-literature
Sort   by:  
 Page size